Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Dry Eye Diaries: Hear Tales and Hopes from Leaders of Shire, Johnson & Johnson, and TearSolutions

    Dry Eye Diaries: Hear Tales and Hopes from Leaders of Shire, Johnson & Johnson, and TearSolutions

    FromOIS Podcast | Ophthalmology's leading Podcast

    Start listeningView podcast show

    Dry Eye Diaries: Hear Tales and Hopes from Leaders of Shire, Johnson & Johnson, and TearSolutions

    FromOIS Podcast | Ophthalmology's leading Podcast

    ratings:
    Length:
    31 minutes
    Released:
    Nov 21, 2017
    Format:
    Podcast episode

    Description

    In interviews at OIS@AAO, we talk with Robert Dempsey, global head of Shire’s ophthalmic business, about the international launch of Xiidra. Joseph Boorady, CEO and president of TearScience, lays out the company’s plans since being acquired by Johnson & Johnson Vision. Finally, Tom Gadek, president and CEO of TearSolutions, explains how he’s hoping to score another winning dry eye treatment with a start-up.
    Released:
    Nov 21, 2017
    Format:
    Podcast episode

    Titles in the series (100)

    Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.